Outcomes of Treatment and Factors Influencing Prognosis in Ugandan Children with Acute Myeloid Leukaemia - Top-Institutions - MDSpire

Outcomes of Treatment and Factors Influencing Prognosis in Ugandan Children with Acute Myeloid Leukaemia

  • By

  • Richard Nyeko

  • Mariana Kruger

  • Nixon Niyonzima

  • Barnabas Atwiine

  • Jennifer Zungu

  • Joyce Balagadde Kambugu

  • Stijn Verhulst

  • Jaques van Heerden

  • December 18, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Pediatric Leukemia Research

  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Leukemia Research

  • #3

    Children's Oncology Group (COG)
    Children's Oncology Group (COG)

    Arcadia, CA

    Key Differentiators

    • Pediatric Oncology Research
    • Clinical Trials

  • #4

    University of Cape Town, Red Cross War Memorial Children's Hospital
    University of Cape Town, Red Cross War Memorial Children's Hospital

    Cape Town, Western Cape

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Global Health

  • #5

    Makerere University College of Health Sciences
    Makerere University College of Health Sciences

    Kampala, Uganda

    Key Differentiators

    • Pediatric Oncology
    • Global Health Research

Original Source(s)

Outcomes of Treatment and Factors Influencing Prognosis in Ugandan Children with Acute Myeloid Leukaemia

  • by Richard Nyeko, Mariana Kruger, Nixon Niyonzima, Barnabas Atwiine, Jennifer Zungu, Joyce Balagadde Kambugu, Stijn Verhulst, Jaques van Heerden

  • December 18, 2025

Related Content

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer